Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The MIRAD-study
NCT02809963Phase 4Completed
- Sponsor
- Herlev Hospital
- Start
- Nov 2015
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in type 2 diabetes mellitus (T2DM), sponsored by Herlev Hospital. Started Nov 2015; status: completed.
02
Drugs
eplerenone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02809963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02809963.